Clinical Trials Directory

Trials / Completed

CompletedNCT02140567

Syncope Prediction Study

Status
Completed
Phase
Study type
Observational
Enrollment
140 (actual)
Sponsor
Medtronic BRC · Industry
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to perform a prospective evaluation of the vasovagal syncope prediction algorithm, called Tilt Test Analyzer, during head up tilt testing tests in one center in the United Kingdom.

Detailed description

Vasovagal syncope (VVS) is a form of neurally-mediated reflex syncope, which is marked by a sudden fall in blood pressure with an associated fall in heart rate often resulting in syncope, head-up tilt (HUT) testing is commonly used to bring information about VVS using ECG and blood pressure monitoring with medical observation. We developed an algorithm, called Tilt Test Analyzer, to predict VVS during HUT based on the simultaneous analysis of heart rate (RR interval), systolic blood pressure (SBP) and an indicator of autonomic modulation represented by heart rate and blood pressure variability (HRV and BPV). The primary objective of this study is to evaluate the VVS prediction algorithm in a prospective cohort of patients in the tilt laboratory The primary endpoint is the VVS prediction algorithm performance by means of measuring the sensitivity and specificity values. The study is designed to test if the prospective analysis of tilt-test patients can reproduce the results previously obtained in the published retrospective analysis on 1155 patients with a similar clinically relevant sensitivity and specificity.

Conditions

Timeline

Start date
2014-11-01
Primary completion
2016-10-01
Completion
2016-11-01
First posted
2014-05-16
Last updated
2019-03-15
Results posted
2018-08-27

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02140567. Inclusion in this directory is not an endorsement.